AEON Biopharma, Inc. Class A AEON 深 滬
等待開盤 04-02 09:30:00 美东时间
0.9784
-0.007
-0.67%
華盛通- 最 高1.02
- 今 開1.0185
- 成交量 10.41万股
- 最 低 0.9502
- 昨 收 0.985
- 總市值 2475.65万
- 52周最高 1.45
- 市盈率 靜 --
- 換手率 0.41%
- 52周最低 0.3788
- 委 比 -14.94%
- 總股本 2530.31万
- 歷史最高 1236.24
- 量 比 0.67
- 振 幅 7.09%
- 歷史最低 0.9112
- 每 手 1
- 風險率 0.23%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多AEON Biopharma Q4 EPS $(3.72)
AEON Biopharma (AMEX:AEON) reported quarterly losses of $(3.72) per share. This is a 199.2 percent decrease over earnings of $3.75 per share from the same period last year.
03-31 04:34
AEON Biopharma Announces Feedback From FDA Following Biosimilar BPD Type 2a Meeting; Co Plans To Request BPD Type 2b Meeting With FDA In 2026 To Discuss Development Of ABP-450 As Biosimilar To BOTOX
FDA provided constructive feedback on Company's analytical similarity strategy under the 351(k) biosimilar pathway Company continues to execute its analytical program and plans to request a BPD Type 2b meeting with
03-25 20:06
AEON Biopharma Names John Bencich As CFO
AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE:AEON), a biopharmaceutical company advancing ABP-450 (prabotulinumtoxinA) as a biosimilar to BOTOX® (onabotulinumtoxinA) to achieve accelerated and full-label
03-10 04:13
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers IO Biotech (NASDAQ:IOBT) stock increased by 76.7% to $0.37 during Thur...
01-23 01:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Athira Pharma (NASDAQ:ATHA) stock increased by 30.6% to $5.4 during Th...
2025-12-18 20:05
AEON Biopharma Q3 EPS $(0.39) Beats $(0.43) Estimate
AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.43) by 9.3 percent. This is a 96.61 percent increase over losses of $(11.52) per share from the
2025-11-14 21:40
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Mersana Therapeutics (NASDAQ:MRSN) stock increased by 205.0% to $27.05...
2025-11-14 01:06
AEON Biopharma Announces Two Complementary Transaction Of ~$22M, Eliminating Nearly All Debt
AEON Biopharma, Inc. ("AEON" or the "Company") (NYSE:AEON), a biopharmaceutical company seeking accelerated and full-label U.S. market entry by developing ABP-450 (prabotulinumtoxinA) as a BOTOX®
2025-11-13 21:40
美股大行评级 | 最高186美元！戴尔科技或多家机构上调目标价； 高盛上调超微公司目标价至210美元
今日重点评级关注：富国银行：维持Kyverna Therapeutics"超配"评级，目标价从24美元升至27美元；Chardan Capital：维持Oculis Holding"买入"评级，目标价从33美元升至51美元
2025-10-09 10:51
Aegis Capital Reiterates Buy on AEON Biopharma, Maintains $7.2 Price Target
Aegis Capital analyst David Bouchey reiterates AEON Biopharma (AMEX:AEON) with a Buy and maintains $7.2 price target.
2025-10-09 00:43
